FDA ruling on compounding goes Endo's way
March 05, 2019 at 11:12 AM EST
The federal agency determined said there is no clinical need to compound vasopressin, a decision that benefits Endo.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|